KIMBERLEE ADAMS: Open Payments
NPI 1831257765 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$134 in 8 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $141 · 2025 $134
Food & beverage: $134
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 2 | $33 |
| Ultragenyx Pharmaceutical Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
| HARMONY BIOSCIENCES LLC | 1 | $16 |
| Corcept Therapeutics | 1 | $15 |
| CSL Behring | 1 | $14 |
Products named: GVOKE HYPOPEN, Dojolvi, NINLARO, JOURNAVX, WAKIX, Korlym, Haegarda.
Industry payments across DE — which companies pay providers there.
